YHB Investment Advisors Inc. Sells 1,631 Shares of CME Group Inc. (NASDAQ:CME)

YHB Investment Advisors Inc. trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 14.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,869 shares of the financial services provider’s stock after selling 1,631 shares during the period. YHB Investment Advisors Inc.’s holdings in CME Group were worth $2,178,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CME. Brookstone Capital Management increased its holdings in shares of CME Group by 3.4% during the 1st quarter. Brookstone Capital Management now owns 27,230 shares of the financial services provider’s stock worth $5,862,000 after purchasing an additional 903 shares during the period. Fifth Third Wealth Advisors LLC lifted its position in CME Group by 224.6% in the first quarter. Fifth Third Wealth Advisors LLC now owns 4,531 shares of the financial services provider’s stock worth $976,000 after purchasing an additional 3,135 shares during the period. Artemis Investment Management LLP boosted its stake in CME Group by 32.6% during the first quarter. Artemis Investment Management LLP now owns 55,342 shares of the financial services provider’s stock worth $11,908,000 after buying an additional 13,598 shares in the last quarter. Trifecta Capital Advisors LLC boosted its position in shares of CME Group by 2.6% during the 1st quarter. Trifecta Capital Advisors LLC now owns 6,175 shares of the financial services provider’s stock valued at $1,329,000 after acquiring an additional 159 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. increased its stake in CME Group by 83.0% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 7,630 shares of the financial services provider’s stock valued at $1,643,000 after acquiring an additional 3,461 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Trading Up 0.4 %

Shares of NASDAQ CME opened at $227.14 on Thursday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.12. The firm has a market capitalization of $81.79 billion, a P/E ratio of 25.84, a P/E/G ratio of 7.76 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The company’s 50 day simple moving average is $218.08 and its 200 day simple moving average is $208.66.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.30 earnings per share. On average, analysts predict that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is 52.33%.

Analyst Upgrades and Downgrades

CME has been the subject of a number of analyst reports. TD Cowen started coverage on shares of CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 price target for the company. Oppenheimer lifted their price objective on CME Group from $228.00 to $245.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Barclays raised their price objective on shares of CME Group from $209.00 to $219.00 and gave the stock an “equal weight” rating in a report on Monday, October 7th. Finally, Morgan Stanley lifted their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. According to MarketBeat.com, CME Group currently has an average rating of “Hold” and an average price target of $220.07.

Insider Activity at CME Group

In related news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.